Advertisement
THC vs UHS
Which Stock Would AI Choose? Tenet Healthcare Corporation (THC) vs. Universal Health Services (UHS) Stock Comparison
Key Takeaways
- Both THC and UHS operate acute care hospitals and have delivered strong quarterly revenue growth above 9% in recent reports, reflecting resilience in healthcare demand.
- UHS trades at a lower trailing P/E ratio (price-to-earnings ratio) of 7.77 compared to THC's 11.98, suggesting better value on current earnings.
- THC exhibits higher return on equity (ROE, a measure of profitability relative to shareholders' equity) at 27.02% versus UHS's 21.37%, indicating superior capital efficiency.
- Year-to-date (YTD), UHS has outperformed with +17.58% returns compared to THC's +9.01%, though both faced recent pullbacks amid broader market volatility.
- Analyst price targets imply significant upside for both, with THC at an average of $262.90 from recent levels around $181, and UHS at $247.35.
Introduction
Tenet Healthcare Corporation (THC) and Universal Health Services, Inc. (UHS) are prominent players in the U.S. hospital and healthcare services sector, operating acute care facilities amid rising demand for medical services. This stock comparison analyzes their recent market performance, financial metrics, and growth drivers, offering insights for value-oriented investors, growth seekers, and traders monitoring healthcare relative performance. With both stocks experiencing volatility in recent weeks due to earnings cycles and sector pressures, understanding their positioning helps evaluate opportunities in a defensive yet expanding industry.
THC Overview and Recent Performance
Tenet Healthcare Corporation (THC) provides hospital and outpatient care through its Conifer Health Solutions segment and ambulatory surgery centers. In recent market activity, shares traded around $181, down from a 52-week high of $247 amid broader healthcare sector rotations. The company reported strong Q4 2025 results with revenue of $5.53 billion, up 9% year-over-year, and EPS (earnings per share) beating estimates, driven by higher patient volumes and ambulatory growth. YTD gains stand at 9.01%, supported by operating margins near 17.5%, though recent weeks saw pullbacks on valuation concerns post-earnings. Positive analyst sentiment, with buy ratings and targets implying over 40% upside, has bolstered market positioning, reflecting confidence in THC's diversification beyond traditional hospitals.
UHS Overview and Recent Performance
Universal Health Services, Inc. (UHS) manages general and acute care hospitals, behavioral health facilities, and surgical centers across the U.S. Shares recently hovered near $180, retreating from a 52-week high of $246, with YTD performance at +17.58% reflecting solid fundamentals. Q1 2026 earnings showcased revenue of $4.5 billion, up 9.7% year-over-year, and adjusted EPS of $5.62 exceeding forecasts, fueled by acute care strength despite cost pressures. Recent weeks brought declines amid market gains, but profitability metrics like an 8.6% profit margin and quarterly revenue growth of 9.6% underscore resilience. Analyst targets around $247 signal optimism for UHS's scale and behavioral health exposure.
Trending AI Robots
Tickeron's Trending AI Robots page curates the top-performing AI trading bots from over 350 total bots that analyze and trade thousands of tickers across stocks, ETFs, and crypto. Only 25+ bots earn a spot in this section based on real-time adaptation to current market conditions, showcasing diverse strategies like short-term scalping (5-60 minute timeframes), swing trading, or long-term signals using technical and fundamental analysis. These bots feature metrics such as win rates above 60%, profit factors exceeding 1.5, and average gains tailored to low, medium, or high volatility environments. With risk management and copy-trading options, they cater to various styles—explore them to align with your trading approach in dynamic markets like healthcare.
Head-to-Head Comparison
Both THC and UHS focus on hospital operations but differ in emphasis: THC leans into ambulatory services for higher-margin growth, while UHS balances acute and behavioral health for diversified revenue. Growth drivers align with patient volume increases, with similar quarterly revenue gains around 9%, though THC's EPS growth edges higher at 16.7%. Recent momentum favors UHS YTD, but THC's superior operating margins (17.5% vs. 11.2%) and ROE highlight efficiency trade-offs. Risks include regulatory pressures and labor costs for both, with betas above 1.0 signaling volatility. Market sentiment tilts bullish via analyst upgrades, yet UHS's lower P/E offers value contrast to THC's growth premium in healthcare stock comparisons.
Tickeron AI Verdict
Tickeron's AI currently favors THC with higher probability due to consistent trend strength, elevated ROE (27%), and analyst targets projecting greater relative upside amid ambulatory catalysts. UHS remains compelling for value plays, but THC's profitability edge positions it better for sustained outperformance in recent market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is THC is a Hold and UHS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
THC’s FA Score shows that 0 FA rating(s) are green whileUHS’s FA Score has 1 green FA rating(s).
- THC’s FA Score: 0 green, 5 red.
- UHS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
THC’s TA Score shows that 4 TA indicator(s) are bullish while UHS’s TA Score has 4 bullish TA indicator(s).
- THC’s TA Score: 4 bullish, 5 bearish.
- UHS’s TA Score: 4 bullish, 4 bearish.
Price Growth
THC (@Hospital/Nursing Management) experienced а +8.33% price change this week, while UHS (@Hospital/Nursing Management) price change was -2.46% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +3.37%. For the same industry, the average monthly price growth was +4.72%, and the average quarterly price growth was +24.53%.
Reported Earning Dates
THC is expected to report earnings on Jul 16, 2026.
UHS is expected to report earnings on Jul 27, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+3.37% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| THC | UHS | THC / UHS | |
| Capitalization | 15.4B | 8.55B | 180% |
| EBITDA | 4.88B | 2.8B | 174% |
| Gain YTD | -10.175 | -35.055 | 29% |
| P/E Ratio | 9.28 | 5.90 | 157% |
| Revenue | 21.9B | 17.8B | 123% |
| Total Cash | 2.97B | N/A | - |
| Total Debt | 13.2B | 5.13B | 258% |
THC | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 35 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 61 | 64 | |
P/E GROWTH RATING 1..100 | 68 | 88 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (11) in the Hospital Or Nursing Management industry is significantly better than the same rating for THC (78). This means that UHS’s stock grew significantly faster than THC’s over the last 12 months.
THC's Profit vs Risk Rating (35) in the Hospital Or Nursing Management industry is somewhat better than the same rating for UHS (100). This means that THC’s stock grew somewhat faster than UHS’s over the last 12 months.
THC's SMR Rating (100) in the Hospital Or Nursing Management industry is in the same range as UHS (100). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
THC's Price Growth Rating (61) in the Hospital Or Nursing Management industry is in the same range as UHS (64). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
THC's P/E Growth Rating (68) in the Hospital Or Nursing Management industry is in the same range as UHS (88). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
| THC | UHS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 68% |
| Stochastic ODDS (%) | 1 day ago 60% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 55% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 73% |
| Advances ODDS (%) | 3 days ago 81% | 7 days ago 70% |
| Declines ODDS (%) | 17 days ago 67% | 17 days ago 68% |
| BollingerBands ODDS (%) | 1 day ago 53% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 73% |
Advertisement
THC and
Correlation & Price change
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.
UHS and
Correlation & Price change
A.I.dvisor indicates that over the last year, UHS has been loosely correlated with HCA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % | ||
|---|---|---|---|---|
| UHS | 100% | -3.84% | ||
| HCA - UHS | 63% Loosely correlated | -2.21% | ||
| THC - UHS | 56% Loosely correlated | -2.76% | ||
| PNTG - UHS | 40% Loosely correlated | +2.07% | ||
| ENSG - UHS | 39% Loosely correlated | -0.69% | ||
| CON - UHS | 35% Loosely correlated | -0.28% | ||
More | ||||